Colorectal Cancer | Neuroendocrine Tumors | Cellular Therapy, 03/13/2024

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Who Needs Chemo After Colorectal Cancer Surgery?   Results from a new study suggest that the presence of circulating tumor DNA (ctDNA) in blood samples can predict which people with colorectal cancer should and shouldn't get chemotherapy after surgery to remove their tumors. Read More Lutathera Shows Promise for Some Neuroendocrine Tumors   A first-of-its-kind trial has shown that people with advanced neuroendocrine tumors in the digestive system may benefit from treatment that includes Lu 177-dotatate (Lutathera). This drug is a radiopharmaceutical, which works differently than many other cancer drugs. Read More First Cellular Therapy Approved for Melanoma   The Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first cancer treatment that uses immune cells called tumor-infiltrating lymphocytes, or TILs. Lifileucel is also the first cellular therapy to be approved for a solid tumor, the skin cancer melanoma. Read More Genetic Risk of New Cancers Among Childhood Cancer Survivors A new study shows that common inherited genetic factors that predict cancer risk in the general population may also predict the risk of new cancers later in life among childhood cancer survivors. Read More CT Scans and Cancer This updated page explains what CT scans are, how they're used for cancer screening, diagnosis, and treatment, and what you can expect during the procedure. Read More Oral Complications of Cancer Therapies Mouth and throat problems are common problems of cancer treatment. This updated page explains ways to prevent and manage problems like dry mouth, taste changes, pain, and infection. Read More Acute Myeloid Leukemia Treatment Acute myeloid leukemia (AML) is a cancer that causes the rapid growth of abnormal white blood cells. These abnormal cells can replace healthy blood cells, leading to symptoms such as easy bleeding, anemia, and infection. Learn more about AML on this recently updated page, including its causes, symptoms, diagnosis, and treatment options. Read More   Contact Us   Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892